Marshall Wace’s European Wax Center EWCZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-655,720
Closed -$2.36M 3337
2025
Q4
$2.36M Sell
655,720
-21,391
-3% -$79.9K ﹤0.01% 1500
2025
Q3
$2.7M Sell
677,111
-47,038
-6% -$215K ﹤0.01% 1473
2025
Q2
$4.08M Buy
724,149
+565,099
+355% +$2.57M ﹤0.01% 1243
2025
Q1
$628K Sell
159,050
-335,481
-68% -$2M ﹤0.01% 1978
2024
Q4
$3.3M Buy
494,531
+194,931
+65% +$1.28M ﹤0.01% 1245
2024
Q3
$2.04M Sell
299,600
-30,070
-9% -$233K ﹤0.01% 1359
2024
Q2
$3.27M Buy
+329,670
New +$3.75M ﹤0.01% 1161
2024
Q1
Sell
-63,100
Closed -$858K 2546
2023
Q4
$858K Sell
63,100
-176,635
-74% -$2.56M ﹤0.01% 1525
2023
Q3
$3.88M Buy
239,735
+195,235
+439% +$3.52M 0.01% 967
2023
Q2
$829K Sell
44,500
-12,631
-22% -$226K ﹤0.01% 1800
2023
Q1
$1.09M Sell
57,131
-57,622
-50% -$1.01M ﹤0.01% 1767
2022
Q4
$1.43M Buy
+114,753
New +$1.65M ﹤0.01% 1910
2022
Q3
Sell
-30,768
Closed -$543K 3462
2022
Q2
$543K Sell
30,768
-205,359
-87% -$5.24M ﹤0.01% 2752
2022
Q1
$6.98M Buy
236,127
+226,743
+2,416% +$5.9M 0.01% 1139
2021
Q4
$285K Buy
+9,384
New +$266K ﹤0.01% 3049

Other funds holding EWCZ

Marshall Wace's EWCZ Position: Q1 2026 in Review

Marshall Wace sold out of European Wax Center (EWCZ) in Q1 2026, closing a stake of 655,720 shares — an estimated $2.36M sold.

Marshall Wace first reported a position in EWCZ in Q4 2021 and held it in 15 quarters. The position peaked at $6.98M in Q1 2022. 120 funds tracked by Wall St. Rank hold EWCZ as of Q1 2026.

  • Marshall Wace reported no remaining European Wax Center position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 655,720 European Wax Center shares in Q1 2026, an estimated $2.36M.
  • Marshall Wace first reported a position in European Wax Center in Q4 2021 and held it in 15 quarters.
  • Marshall Wace's European Wax Center position peaked at $6.98M in Q1 2022.
  • 120 funds tracked by Wall St. Rank held European Wax Center as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.